Intellectual Property in AI-Driven Drug Discovery: From Algorithms to Clinical Trials.
Artificial intelligence (AI) is driving transformative change in the rapidly evolving field of drug discovery. Traditionally, developing new drugs has been a lengthy and costly endeavour, often requiring up to a decade and billions of dollars to complete. Now, however, AI is accelerating and enhancing the entire process, from the [...]